Johnny Im

Johnny Im serves as the US Head of Marketing at Almirall, leading efforts in commercial strategy and promotional activities for new product launches since December 2020. Previous roles include Director of Neuroscience Payor and Market Access at The Janssen Pharmaceutical Companies of Johnson & Johnson, and Principal at Simitris Life Sciences LLC. Notably, Johnny has held positions at AstraZeneca, where marketing leadership led to substantial increases in patient engagement for the BRILINTA brand, and Iroko Pharmaceuticals, where Johnny contributed to the company's growth from $0 to over $100 million in sales. The career also includes significant experience at GlaxoSmithKline, with various roles advancing through Product Management to Senior Product Manager. Johnny holds a BA in Architecture from Washington University in St. Louis.